Wayne, PA, United States of America

David A Berges


Average Co-Inventor Count = 1.1

ph-index = 6

Forward Citations = 128(Granted Patents)

Forward Citations (Not Self Cited) = 93(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Audubon, PA (US) (1976 - 1977)
  • Wayne, PA (US) (1976 - 1981)
  • Phoenixville, PA (US) (1979 - 1999)
  • Provo, UT (US) (1997 - 2000)

Company Filing History:


Years Active: 1976-2000

Loading Chart...
56 patents (USPTO):Explore Patents

Title: David A Berges: Innovator Extraordinaire

Introduction:

David A Berges, a brilliant inventor and patent holder, has made significant contributions to the field of pharmaceuticals with his groundbreaking innovations. With an impressive portfolio of 56 patents, Berges has revolutionized cancer treatment and viral infection therapies. Hailing from Wayne, PA (USA), his remarkable achievements have earned him recognition and admiration across the industry.

Latest Patents:

Berges's most recent patents include two significant inventions. The first patent involves water-soluble camptothecin analogs, which have proven to be highly effective antineoplastic agents. These compounds, represented by Formula I, have demonstrated their potential in inhibiting the growth of tumor cells and hold promise in cancer treatment.

In his second patent, Berges presents a method for treating viral infections using antiviral substituted indolizino[1,2-b]quinolinone compounds. These innovative compounds and their pharmaceutical compositions offer a novel approach to combating viral infections.

Career Highlights:

Throughout his illustrious career, David A Berges has made significant contributions to the pharmaceutical industry. He has been associated with reputable companies such as SmithKline Corporation and SmithKline Beecham Corporation, where he has undertaken pioneering research and development projects.

Berges has been instrumental in developing novel therapeutic strategies, particularly in the field of oncology and antiviral treatments. His patents and inventions have not only advanced the scientific understanding of disease mechanisms but have also laid the foundation for innovative therapies.

Collaborations:

Collaboration plays a crucial role in the realization of groundbreaking innovations, and David A Berges has had the privilege of working alongside esteemed colleagues. Notable among them are John J Taggart and Robert Philip Hertzberg, both recognized experts in their respective fields. The combined expertise of these accomplished professionals has undoubtedly paved the way for groundbreaking discoveries and advancements in the pharmaceutical industry.

Conclusion:

David A Berges's remarkable career journey, highlighted by his 56 patents and profound contributions to the pharmaceutical field, is a testament to his expertise and dedication. His inventions, such as water-soluble camptothecin analogs and antiviral indolizino[1,2-b]quinolinone compounds, have the potential to reshape cancer treatment and viral infection therapies.

Berges's collaborations and associations with renowned companies and colleagues further exemplify his commitment to excellence and his drive to push the boundaries of innovation. His contributions have undoubtedly made a significant impact on the lives of patients worldwide, and he stands as an inspiration to aspiring inventors and researchers in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…